Clinical trial

The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study

NCT02585258

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-30

PhasePHASE4

Study timeline

Study start (actual)2016-06-30Date precision: day

Registry last updated2023-07-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

RheumatoId Arthritisunresolved

Interventions

PrednisoloneDRUG · verified · RxNorm: prednisolone

PlaceboDRUG

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

European Commissioncollaborator

Mapped research locations

LisbonPortugal3 BucharestRomania2 BerlinGermany1 AmsterdamNetherlands1 GroningenNetherlands1 RotterdamNetherlands1 BratislavaSlovakia1 DebrecenHungary1 GenovaItaly1 MaastrichtNetherlands1 UtrechtNetherlands1 CoimbraPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02585258 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.